GET THE REBATE

Insured patients:
Register below for your Epiduo® (adapalene and benzoyl peroxide) Gel 0.1% / 2.5% Instant Advantage Card. Insured patients could pay no more than $35* for their Epiduo® Gel prescription (for one tube, after primary insurance and the Epiduo® Gel Instant Advantage Card).

Uninsured and cash patients:
Register below for your Epiduo® Gel Instant Advantage Card, which could reduce your out-of-pocket cost for Epiduo® Gel by up to $50.

Galderma is committed to protecting and safeguarding your privacy. To better understand how we use the data you provide from this site, please read our Privacy Policy. We will not sell your information, and you will not receive anything from us that you have not agreed to receive.

**Required field

**First Name:
**Last Name:
**Address 1:
Address 2:
**City:
**State:
**ZIP Code:
**Email:
**Email Confirmation:
**Date of Birth:
    
**Gender:

** How long have you been dealing with breakouts?

** Have you seen a doctor about treatment yet?

** How do you plan to use your Epiduo® Gel rebate?

Rebates are not valid for prescriptions reimbursed under a federally funded healthcare program, including Medicare or Medicaid as well as similar state programs, including any state medical assistance programs. Offer void where prohibited by law, taxed, or restricted. Offer good in and rebates emailed to addresses in the U.S.A. only. Offer good only in the United States and D.C. Void in Minnesota, Massachusetts, Michigan, and Rhode Island, except for prescriptions that are not reimbursed by any third-party payer. Galderma Laboratories, L.P. reserves the right to rescind, revoke, or amend this offer at any time without notice. Galderma Laboratories, L.P., its officers, directors and employees, parent, subsidiaries and related companies, are not responsible for any injury or loss whatsoever resulting from technical, hardware or software failures or malfunctions, and are not responsible for illegible, lost, late, mutilated or postage due submissions.

You could pay no more than $35* and download the Blame Biology kit

Learn more

Track your progress

Get the mobile app

Help your teen take action

Make a plan

Get the doctor discussion guide

Download the PDF

Important Safety Information
Epiduo® Gel is indicated for the topical treatment of acne vulgaris in patients 12 years and older. Apply to affected skin once daily, avoiding the eyes, lips and mucous membranes. The most common adverse events associated with use of Epiduo® Gel are redness, scaling, dryness, stinging and burning. In addition, you may also experience contact dermatitis and/or skin irritation. These side effects typically resolve during the first four weeks of treatment, but speak to your doctor if they persist. You should avoid excessive exposure to sunlight and sunlamps while using Epiduo® Gel, and use of sunscreen products and protective clothing is recommended. Do not use irritating topical products that contain resorcinol, salicylic acid or sulfur when using Epiduo® Gel. Epiduo® Gel has not been tested in pregnant or nursing women, or with the elderly. Pregnancy Category C. Please see Full Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

* Insured patients could pay no more than $35 for their Epiduo® Gel prescription (for one tube, after primary insurance and the Epiduo® Gel Instant Advantage Card). Restrictions may apply.

©2012 Galderma Laboratories, L.P. United States, All Rights Reserved. All trademarks are the property of their respective owners. This site intended for U.S. audiences only. Information in this website is not intended as medical advice. Talk to your doctor about medical concerns.

Important Safety Information

Close

Epiduo® Gel is indicated for the topical treatment of acne vulgaris in patients 12 years and older. Apply to affected skin once daily, avoiding the eyes, lips and mucous membranes. The most common adverse events associated with use of Epiduo® Gel are redness, scaling, dryness, stinging and burning. In addition, you may also experience contact dermatitis and/or skin irritation. These side effects typically resolve during the first four weeks of treatment, but speak to your doctor if they persist. You should avoid excessive exposure to sunlight and sunlamps while using Epiduo® Gel, and use of sunscreen products and protective clothing is recommended. Do not use irritating topical products that contain resorcinol, salicylic acid or sulfur when using Epiduo® Gel. Epiduo® Gel has not been tested in pregnant or nursing women, or with the elderly. Pregnancy Category C. Please see Full Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

TWITTER FACEBOOK GOOGLE BUZZ EMAIL
Close

SHARE THE NEWS

All fields are required.

Your Email Address:

Your Name:

Recipient's Email Address:

Send me a copy of this email

View our Privacy Policy